Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540306 · ClinicalTrials.gov registry record
Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy
A clinical trial of Accessory; Breast Tissue, sponsored by University of California, Irvine.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT00540306 is a study of Accessory; Breast Tissue that has completed, run by University of California, Irvine. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00540306, a study of Accessory; Breast Tissue, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to do determine the changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy. The Researcher can determine 1) how large variations in breast tissue components are 2) how predictable and repeatable these variations are 3) the effects of endogenous hormones on breast tissue physiology.
Conditions Studied
Interventions
- DEVICE Diffuse Optical Spectroscopy
Study Locations (1)
California
- Beckman Laser Institute University of California Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-02 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00540306
The ClinicalTrials.gov registry entry for NCT00540306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Accessory; Breast Tissue appearing as the primary indexed condition, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00540306 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00540306 about?
NCT00540306 is a clinical study titled "Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy". The purpose of this study is to do determine the changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy. The Researcher can determine 1) how large variations in breast tissue components are 2) how predicta...
What is the current status of trial NCT00540306?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2006-02. Estimated completion is 2012-10.
What conditions does trial NCT00540306 study?
This clinical trial studies the following conditions: Accessory; Breast Tissue.
What interventions are being tested in trial NCT00540306?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00540306?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00540306 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.